Hillman Capital Management, Inc. Biogen Inc. Transaction History

Hillman Capital Management, Inc.

$190 Million
Q1 2025

A detailed history of Hillman Capital Management, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Hillman Capital Management, Inc. holds 44,025 shares of BIIB stock, worth $5.59 Million. This represents 3.17% of its overall portfolio holdings.

Number of Shares

44,025

Previous 43,066 2.23%

Holding current value

$5.59 Million

Previous $6.59 Million 8.52%

% of portfolio

3.17%

Previous 2.57%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$133.43 - $153.27 $127,959 - $146,985	959 Added 2.23%	44,025 $6.02 Million
Q4 2024 Feb 14, 2025	BUY	$146.47 - $191.55 $1.14 Million - $1.5 Million	7,813 Added 22.16%	43,066 $6.59 Million
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $132,538 - $165,996	-701 Reduced 1.95%	35,253 $6.83 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $30,864 - $38,348	162 Added 0.45%	35,954 $8.33 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $279,018 - $352,306	1,316 Added 3.82%	35,792 $7.72 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $37,840 - $45,549	170 Added 0.5%	34,476 $8.92 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $1.24 Million - $1.4 Million	4,895 Added 16.64%	34,306 $8.82 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $34,406 - $39,757	-125 Reduced 0.42%	29,411 $8.38 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $138,542 - $157,863	-540 Reduced 1.8%	29,536 $8.21 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $423,594 - $514,676	-1,678 Reduced 5.28%	30,076 $8.33 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $2.19 Million - $3.02 Million	-11,265 Reduced 26.19%	31,754 $8.48 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $63,763 - $75,826	340 Added 0.8%	43,019 $8.77 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $3 Million - $3.78 Million	15,488 Added 56.96%	42,679 $8.99 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $245,864 - $315,971	-1,098 Reduced 3.88%	27,191 $6.52 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $297,139 - $387,502	1,050 Added 3.85%	28,289 $8.01 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $12,950 - $20,735	-50 Reduced 0.18%	27,239 $9.43 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $1.79 Million - $2.09 Million	7,360 Added 36.93%	27,289 $7.63 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $68,987 - $103,843	292 Added 1.49%	19,929 $4.88 Million
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $897,835 - $1.04 Million	3,391 Added 20.87%	19,637 $5.57 Million
Q2 2020 Aug 04, 2020	SELL	$258.66 - $342.55 $34,660 - $45,901	-134 Reduced 0.82%	16,246 $4.35 Million
Q1 2020 Apr 29, 2020	SELL	$268.85 - $341.04 $466,185 - $591,363	-1,734 Reduced 9.57%	16,380 $5.18 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $3.99 Million - $5.51 Million	18,114 New	18,114 $5.38 Million

Others Institutions Holding BIIB

# of Institutions

1,026

Shares Held

127M

Call Options Held

2.29M

Put Options Held

4.26M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $18.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillman Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillman Capital Management, Inc. with notifications on news.

Account

Hillman Capital Management, Inc. Biogen Inc. Transaction History